CN103739640B - 一种甜菊糖a苷晶体及其制备方法和用途 - Google Patents
一种甜菊糖a苷晶体及其制备方法和用途 Download PDFInfo
- Publication number
- CN103739640B CN103739640B CN201410044560.7A CN201410044560A CN103739640B CN 103739640 B CN103739640 B CN 103739640B CN 201410044560 A CN201410044560 A CN 201410044560A CN 103739640 B CN103739640 B CN 103739640B
- Authority
- CN
- China
- Prior art keywords
- stevioside
- crystal formation
- crystal
- glycosides
- formation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000013078 crystal Substances 0.000 title claims abstract description 161
- 235000019202 steviosides Nutrition 0.000 title claims abstract description 96
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 title claims abstract description 94
- 229940013618 stevioside Drugs 0.000 title claims abstract description 93
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 title claims abstract description 93
- 229930182470 glycoside Natural products 0.000 title claims abstract description 48
- 150000002338 glycosides Chemical class 0.000 title claims abstract description 48
- 238000004519 manufacturing process Methods 0.000 title description 4
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 102
- 238000000634 powder X-ray diffraction Methods 0.000 claims abstract description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 62
- 239000000706 filtrate Substances 0.000 claims description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 25
- 238000000113 differential scanning calorimetry Methods 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 9
- 239000012047 saturated solution Substances 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 10
- 238000002425 crystallisation Methods 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 238000001228 spectrum Methods 0.000 description 9
- 238000001069 Raman spectroscopy Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000002329 infrared spectrum Methods 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000004383 Steviol glycoside Substances 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- VLOVSFJPGNJHMU-UHFFFAOYSA-N ethanol;methanol;hydrate Chemical compound O.OC.CCO VLOVSFJPGNJHMU-UHFFFAOYSA-N 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- -1 methyl alcohol tetrahydrate Chemical class 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000019411 steviol glycoside Nutrition 0.000 description 3
- 229930182488 steviol glycoside Natural products 0.000 description 3
- 150000008144 steviol glycosides Chemical class 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000001512 FEMA 4601 Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000001237 Raman spectrum Methods 0.000 description 2
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 235000019203 rebaudioside A Nutrition 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- ONVABDHFQKWOSV-UHFFFAOYSA-N 16-Phyllocladene Natural products C1CC(C2)C(=C)CC32CCC2C(C)(C)CCCC2(C)C31 ONVABDHFQKWOSV-UHFFFAOYSA-N 0.000 description 1
- 241000189115 Catananche Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 238000001530 Raman microscopy Methods 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000012362 drug development process Methods 0.000 description 1
- 238000012912 drug discovery process Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- ONVABDHFQKWOSV-HPUSYDDDSA-N ent-kaur-16-ene Chemical compound C1C[C@H](C2)C(=C)C[C@@]32CC[C@@H]2C(C)(C)CCC[C@@]2(C)[C@@H]31 ONVABDHFQKWOSV-HPUSYDDDSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 230000008863 intramolecular interaction Effects 0.000 description 1
- 229940002661 lipitor Drugs 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical class [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000004441 surface measurement Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410044560.7A CN103739640B (zh) | 2014-01-30 | 2014-01-30 | 一种甜菊糖a苷晶体及其制备方法和用途 |
PCT/CN2014/080909 WO2015113370A1 (zh) | 2014-01-30 | 2014-06-27 | 一种甜菊糖a苷晶体及其制备方法和用途 |
US15/115,542 US20170051002A1 (en) | 2014-01-30 | 2014-06-27 | Rebaudioside A Crystal And Its Preparation Method And Use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410044560.7A CN103739640B (zh) | 2014-01-30 | 2014-01-30 | 一种甜菊糖a苷晶体及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103739640A CN103739640A (zh) | 2014-04-23 |
CN103739640B true CN103739640B (zh) | 2016-08-17 |
Family
ID=50496725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410044560.7A Active CN103739640B (zh) | 2014-01-30 | 2014-01-30 | 一种甜菊糖a苷晶体及其制备方法和用途 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20170051002A1 (zh) |
CN (1) | CN103739640B (zh) |
WO (1) | WO2015113370A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103739640B (zh) * | 2014-01-30 | 2016-08-17 | 诸城市浩天药业有限公司 | 一种甜菊糖a苷晶体及其制备方法和用途 |
CN105693791B (zh) * | 2016-03-24 | 2018-12-28 | 诸城市浩天药业有限公司 | 甜菊双糖苷晶型a、其制备方法、食品组合物及应用 |
EP3497110A1 (en) * | 2016-08-09 | 2019-06-19 | DSM IP Assets B.V. | Crystallization of steviol glycosides |
CN106866757B (zh) | 2017-03-16 | 2020-06-26 | 诸城市浩天药业有限公司 | 甜菊糖m苷晶型及制备方法和用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101472487A (zh) * | 2006-06-19 | 2009-07-01 | 可口可乐公司 | 甜菊双糖苷a组合物及其纯化方法 |
CN102770436A (zh) * | 2009-12-31 | 2012-11-07 | 可口可乐公司 | 莱鲍迪苷a组合物和纯化莱鲍迪苷a的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101270138B (zh) * | 2007-03-23 | 2011-05-04 | 宁波绿之健药业有限公司 | 一种高含量甜菊糖a3甙的提取方法 |
CN100500685C (zh) * | 2007-08-01 | 2009-06-17 | 江南大学 | 一种从甜菊糖中提取高纯度莱鲍迪a甙的方法 |
WO2010118218A1 (en) * | 2009-04-09 | 2010-10-14 | Cargill, Incorporated | Sweetener composition comprising high solubility form of rebaudioside a and method of making |
CN102286041A (zh) * | 2011-08-25 | 2011-12-21 | 辽宁千千生物科技有限公司 | 一种用重结晶提纯甜菊糖甙的方法 |
CN103739640B (zh) * | 2014-01-30 | 2016-08-17 | 诸城市浩天药业有限公司 | 一种甜菊糖a苷晶体及其制备方法和用途 |
-
2014
- 2014-01-30 CN CN201410044560.7A patent/CN103739640B/zh active Active
- 2014-06-27 WO PCT/CN2014/080909 patent/WO2015113370A1/zh active Application Filing
- 2014-06-27 US US15/115,542 patent/US20170051002A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101472487A (zh) * | 2006-06-19 | 2009-07-01 | 可口可乐公司 | 甜菊双糖苷a组合物及其纯化方法 |
CN102770436A (zh) * | 2009-12-31 | 2012-11-07 | 可口可乐公司 | 莱鲍迪苷a组合物和纯化莱鲍迪苷a的方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2015113370A1 (zh) | 2015-08-06 |
US20170051002A1 (en) | 2017-02-23 |
CN103739640A (zh) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103739640B (zh) | 一种甜菊糖a苷晶体及其制备方法和用途 | |
ES2562643T3 (es) | Conjugado de naloxol-PEG cristalino | |
CN105037458A (zh) | 一种甜菊糖d苷晶型a、其制备方法及其应用 | |
CN108864077A (zh) | 小檗碱有机酸盐的固体形式及其制备方法 | |
CN107531646A (zh) | 尿嘧啶化合物的新型结晶 | |
Chandel et al. | Co-crystalization of aceclofenac and paracetamol and their characterization. | |
CN105111215A (zh) | 一种周期蛋白依赖性激酶抑制剂的晶型及其制备方法 | |
CN103739639B (zh) | 一种甜菊糖a苷晶体及其制备方法和用途 | |
Wang et al. | Drug-drug cocrystals of theophylline with quercetin | |
CN106083792A (zh) | 右旋的二氢杨梅素一水合物结晶 | |
CN105111164B (zh) | 精茚虫威的晶型 | |
CN105646616A (zh) | 甜菊糖b苷晶型g、其制备方法、食品组合物及应用 | |
CN105693791B (zh) | 甜菊双糖苷晶型a、其制备方法、食品组合物及应用 | |
CN109776416B (zh) | 一种草乌甲素c晶型及其制备方法与应用 | |
JP2022525125A (ja) | ブレイアコニチンaのe結晶形及びその製造方法と応用 | |
CN102336818B (zh) | 一种肽类物质的晶体及其制备方法和用途 | |
CN109651373A (zh) | 一种西格列汀磷酸盐单水合物晶型的制备方法 | |
Yang et al. | Thermodynamic stability analysis of m-nisoldipine polymorphs | |
CN114008023B (zh) | 索吡溴铵的晶型及其制备方法 | |
CN112538070B (zh) | 吡蚜酮-对羟基苯甲酸共晶及其制备方法 | |
CN104829667B (zh) | 一种淫羊藿苷h1晶型、其制法和其药物组合物与应用 | |
CN105859748B (zh) | 多环化合物钠盐及其多晶型、制备方法及应用 | |
CN1594355B (zh) | 环维黄杨星d晶体,其一甲醇结晶体,其制备和用途 | |
CN105085593A (zh) | 瑞加德松的晶型及其制备方法 | |
CN104592009B (zh) | 萘普生药物共晶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a stevioside a crystal and a preparation method and application thereof Effective date of registration: 20210918 Granted publication date: 20160817 Pledgee: Bank of Weifang Zhucheng sub branch Pledgor: ZHUCHENG HAOTIAN PHARM Co.,Ltd. Registration number: Y2021980009630 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221122 Granted publication date: 20160817 Pledgee: Bank of Weifang Zhucheng sub branch Pledgor: ZHUCHENG HAOTIAN PHARM Co.,Ltd. Registration number: Y2021980009630 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A crystal of steviol glycoside A and its preparation method and application Effective date of registration: 20230829 Granted publication date: 20160817 Pledgee: Bank of Weifang Zhucheng sub branch Pledgor: ZHUCHENG HAOTIAN PHARM Co.,Ltd. Registration number: Y2023980054328 |